Editorial board

The journal’s Board nominates and appoints members of the Technical Group for Counselling and Consulting. Depending on their areas of interest, the members of this advisory board may participate in activities associated with the journal and propose and submit changes to the board members for consideration. In addition, they are assumed, first and foremost, to be involved in refereeing proceedings and providing reviews of the contributions received, recommending them (or not) for publishing. However, the final decision on publishing is at the discretion of the editorial board members.

The Editorial Board meets twice a year. During these two sessions any relevant documents and the publishing scheme are discussed and agreed. The meetings are organised and managed by the production department in liaison with the SCAN Association staff. Board membership does not carry any remuneration.

EDITOR-IN-CHIEF

Prof. MUDr. Tomáš Zima, DrSc., MBA

Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic

prof. PhDr. Michal Miovský, Ph.D.

Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic

∴ CV

RG: https://www.researchgate.net/profile/Michal_Miovsky

EXECUTIVE EDITOR

Prof. Ing. Beáta Gavurová, Ph.D., MBA

Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic

EDITORIAL  BOARD MEMBERS

Peter J. Adams, Ph.D.

School of Population Health, The University of Auckland, New Zealand

∴ CV

Roberto Canay, MA, Ph.D.

Obra Social Ferroviaria (OSFE), Argentina
International Society of Substance Use Professionals (ISSUP)
Organization of American States (OAS)

Assoc. Prof. Roman Gabrhelík, Ph.D.

Department of Addictology, First Faculty of Medicine, Charles University
and General University Hospital in Prague, Czech Republic

∴ CV

Lumír Ondřej Hanuš, DrSc., Dr. h. c.

Department of Medicinal Chemistry and Natural Products, School of Pharmacy, Faculty of Medicine,
Hebrew University, Jerusalem, Israel

∴ CV

Dr Yatan Pal Singh Balhara

Professor of Psychiatry, National Drug Dependence Treatment Centre (NDDTC),

WHO Collaborating Center on Substance Abuse, All India Institute of Medical Sciences (AIIMS), New Delhi

∴ https://www.researchgate.net/profile/Yatan-Balhar

Jeffrey T. Lee

Consultant to ISSUP as Senior Consultant and Manager, Scientific Support Team
Advisory Board Member FENIQS-EU (Further Enhancing the Implementation
of Quality Standardsin drug demand reduction in the EU)
Board Member, Applied Prevention Science International (APSI)

Dr. Otto Lesch

Universitätsklinik für Psychiatrie und Psychotherapie,
Medizinische Universität Wien, Wien, Österreich

Peter M. Miller, Ph.D.

Center for Drug and Alcohol Programs, Department of Psychiatry
and Behavioral Sciences,Medical University of South Carolina, Charleston,
SC, U.S.A.

Sylvie Mrug, Ph.D.

University of Alabama at Birmingham, Birmingham, AL, U.S.A.

∴ CV

Roger H. Peters, Ph.D.

University of South Florida

∴ CV

Dr. Med. Iryna Pinchuk, Ph.D.

Institute of Psychiatry of Taras Shevchenko National University of Kyiv
International Technology Transfer Center (Ukraine)
International Consortium of Universities for Drug
Demand Reduction (ICUDDR) and International
Society of Substance Use Professionals (ISSUP)

∴ CV

Kenzie L. Preston, Ph.D.

NIH National Institute of Drug Abuse, Baltimore, MD, U.S.A.

Rasha Abi Hana, MsC, Ph.D.

Scientific Support Coordinator, International Society
of Substance Use Professionals (ISSUP)

Zili Sloboda, Ph.D.

President of Applied Prevention Science International, Mansfield, Ohio, U.S.A.

Wouter Vanderplasschen, Ph.D.

Department of Orthopedagogics, Ghent University, Ghent, Belgium